Biotech · Public company · San Diego, CA, US
Iambic Therapeutics, Inc.
Ticker IAM · SEC CIK 0001997038
Track this companyFree. Adds Iambic Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline1
- IAM1363Phase 1 · HER2 Mutation-Related TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Phase 1/1b Study of IAM1363 in HER2 CancersPHASE1 · RECRUITING · started Mar 25, 2024ClinicalTrials.gov NCT06253871 · fetched Nov 12, 2026